CA2789411A1 - Diagnosis of systemic lupus erythematosus (sle) - Google Patents

Diagnosis of systemic lupus erythematosus (sle) Download PDF

Info

Publication number
CA2789411A1
CA2789411A1 CA2789411A CA2789411A CA2789411A1 CA 2789411 A1 CA2789411 A1 CA 2789411A1 CA 2789411 A CA2789411 A CA 2789411A CA 2789411 A CA2789411 A CA 2789411A CA 2789411 A1 CA2789411 A1 CA 2789411A1
Authority
CA
Canada
Prior art keywords
antigens
reactivity
sample
sle
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2789411A
Other languages
English (en)
French (fr)
Inventor
Irun R. Cohen
Eytan Domany
Noam Shental
Ittai Fattal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tel HaShomer Medical Research Infrastructure and Services Ltd
Yeda Research and Development Co Ltd
Original Assignee
Tel HaShomer Medical Research Infrastructure and Services Ltd
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel HaShomer Medical Research Infrastructure and Services Ltd, Yeda Research and Development Co Ltd filed Critical Tel HaShomer Medical Research Infrastructure and Services Ltd
Publication of CA2789411A1 publication Critical patent/CA2789411A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2789411A 2010-02-12 2011-02-13 Diagnosis of systemic lupus erythematosus (sle) Abandoned CA2789411A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30369110P 2010-02-12 2010-02-12
US61/303,691 2010-02-12
PCT/IL2011/000153 WO2011099012A1 (en) 2010-02-12 2011-02-13 Diagnosis of systemic lupus erythematosus (sle)

Publications (1)

Publication Number Publication Date
CA2789411A1 true CA2789411A1 (en) 2011-08-18

Family

ID=43971423

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2789411A Abandoned CA2789411A1 (en) 2010-02-12 2011-02-13 Diagnosis of systemic lupus erythematosus (sle)

Country Status (8)

Country Link
US (2) US20130035254A1 (cg-RX-API-DMAC7.html)
EP (1) EP2534487B1 (cg-RX-API-DMAC7.html)
JP (1) JP5894539B2 (cg-RX-API-DMAC7.html)
CN (1) CN102762983B (cg-RX-API-DMAC7.html)
AU (1) AU2011213923A1 (cg-RX-API-DMAC7.html)
CA (1) CA2789411A1 (cg-RX-API-DMAC7.html)
ES (1) ES2560809T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011099012A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652999B1 (en) 2012-07-24 2014-02-18 Dow Agrosciences, Llc. Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone
EP2698636A1 (en) * 2012-08-13 2014-02-19 Fundació Institut d'Investigació Biomèdica de Bellvitge Methods and reagents for prevention and/or treatment of transplant rejection
WO2014091490A2 (en) * 2012-12-16 2014-06-19 Yeda Research And Development Co. Ltd. Diagnosis of autoimmune diseases using a specific antibody profile
CN104007266B (zh) * 2013-02-27 2016-04-20 中国医学科学院基础医学研究所 含有6-n-甲基赖氨酸残基的抗原在制备辅助诊断系统性红斑狼疮试剂中的应用
US11531033B2 (en) * 2013-03-15 2022-12-20 Exagen Inc. Methods for treating and diagnosing systemic lupus erythematosus
WO2015101988A1 (en) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
WO2015101987A1 (en) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Methods for assaying immunological competence
EP2933639A1 (en) * 2014-04-16 2015-10-21 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts S100p and Hyaluronic acid as biomarkers for metastatic breast cancer
CA2983796A1 (en) * 2014-04-25 2015-10-29 The Brigham And Women's Hospital, Inc. Compositions and methods for treating subjects with immune-mediated diseases
EP3177930A1 (en) * 2014-08-08 2017-06-14 Allegheny-Singer Research Institute Anti-lymphocyte autoantibodies as diagnostic biomarkers
US11047855B2 (en) 2015-03-01 2021-06-29 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
US11774446B2 (en) 2016-06-20 2023-10-03 Cowper Sciences Inc. Methods for diagnosis and treatment of autoimmune diseases
WO2017223116A2 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
EP3538893A4 (en) 2016-11-11 2020-09-23 Healthtell Inc. PROCESSES FOR IDENTIFYING CANDIDATE BIOMARKERS
EP3555625A1 (en) * 2016-12-16 2019-10-23 Merck Patent GmbH Methods for the use of galectin 3 binding protein detected in the urine for monitoring the severity and progression of lupus nephritis
CN107151672B (zh) * 2017-05-11 2021-05-28 成都医学院 一种重组质粒及其用途
US11480568B2 (en) 2017-09-28 2022-10-25 Yeda Research And Development Co. Ltd. Diagnosis of autoimmune diseases
BR102018075339A2 (pt) * 2018-12-06 2021-11-16 Fundação Oswaldo Cruz Proteína recombinante, sequência de dna sintético, vetor de expressão, célula hospedeira, composição, kit para diagnóstico de rubéola, uso de pelo menos uma proteína recombinante, e, métodos para produzir uma proteína recombinante e para diagnóstico de rubéola

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
AU2001259230A1 (en) * 2000-04-28 2001-11-12 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of polyclonal b cell activation and immunoglobulin class switching topathogenic autoantibodies by blocking cd1-mediated interactions
IL137460A0 (en) 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
CA2764288A1 (en) * 2000-11-27 2002-05-30 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
ES2239532B1 (es) * 2004-02-06 2006-11-01 Proyecto De Biomedicina Cima S.L. Metodo para evaluar el riesgo y la predisposicion a desarrollar una patologia relacionada con la presencia de autoanticuerpos frente a epcr.
US20050260770A1 (en) 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
US20080254482A1 (en) * 2006-11-22 2008-10-16 Invitrogen Corporation Autoimmune disease biomarkers
CN101329341B (zh) * 2008-07-09 2012-06-27 北京美康生物技术研究中心 检测自身免疫疾病相关抗核抗体谱的试剂盒及其制备方法
CN102803965A (zh) 2009-05-05 2012-11-28 耶达研究与发展有限公司 用于识别个人心血管疾病的发生的装置和方法

Also Published As

Publication number Publication date
CN102762983A (zh) 2012-10-31
EP2534487B1 (en) 2015-11-04
EP2534487A1 (en) 2012-12-19
WO2011099012A1 (en) 2011-08-18
US20140342939A1 (en) 2014-11-20
CN102762983B (zh) 2016-01-20
JP5894539B2 (ja) 2016-03-30
ES2560809T3 (es) 2016-02-22
JP2013519875A (ja) 2013-05-30
AU2011213923A1 (en) 2012-08-30
US20130035254A1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
EP2534487B1 (en) Diagnosis of systemic lupus erythematosus (sle)
US11965885B2 (en) Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
US20160069896A1 (en) Diagnosis of autoimmune diseases using a specific antibody profile
US20180231565A1 (en) Methods for determining the risk of a systemic lupus erythematosus (sle) patient to develop neuropsychiatric syndromes
US20130252839A1 (en) Markers of primary graft dysfunction
US11846636B2 (en) Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
US20230003742A1 (en) Non-invasive assay for detecting and monitoring systemic inflammation
Class et al. Patent application title: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS Inventors: Irun R. Cohen (Rehovot, IL) Eytan Domany (Rehovot, IL) Eytan Domany (Rehovot, IL) Noam Shental (Rehovot, IL) Ittai Fattal (Rehovot, IL)
EP2235540A2 (en) New method for diagnosing sjogren's syndrome
HK1178247A (zh) 系统性红斑狼疮(sle)的诊断
WO2015200242A2 (en) Compositions and methods for the diagnosis of systemic autoimmune disease

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160111

FZDE Discontinued

Effective date: 20190213